Defining adherence to prophylaxis in haemophilia
Haemophilia
.
2016 Jul;22(4):e311-4.
doi: 10.1111/hae.12935.
Epub 2016 May 26.
Authors
L H Schrijvers
1
,
M H Cnossen
2
,
M Beijlevelt-Van der Zande
3
,
M Peters
3
,
M J Schuurmans
4
5
,
K Fischer
1
6
Affiliations
1
Van Creveldkliniek, University Medical Center, Utrecht, The Netherlands.
2
Department of Paediatric Haematology, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands.
3
Haemophilia Treatment Center, Emma Children's' Hospital-Academical Medical Center, Amsterdam, The Netherlands.
4
Nursing Science, Faculty of Health Care, University of Applied Science, Utrecht, The Netherlands.
5
Nursing Science, University Medical Centre, Utrecht, The Netherlands.
6
Julius Center for Health Sciences and Primary Care, University Medical Centre, Utrecht, The Netherlands.
PMID:
27227699
DOI:
10.1111/hae.12935
No abstract available
Publication types
Letter
MeSH terms
Coagulants / therapeutic use*
Factor VIII / therapeutic use*
Hemarthrosis / prevention & control
Hemophilia A / drug therapy*
Humans
Medication Adherence*
Substances
Coagulants
Factor VIII